ASCO 2023: ADC Post-Conference Report

Beacon ADC experts have screened each abstract from the 2023 ASCO Annual Meeting, held on 2nd to 6th June. This year, 132 ADC-relevant abstracts (126 clinical and 6 preclinical) were identified and have been listed in order of presentation in our Post-Conference Report.

ASCO 2023: ADC Abstract Highlights

The ASCO Post-Conference Report sample includes additional analysis and insight from our Beacon ADC experts as well as a list of all ADC-relevant abstracts.

You May Also Be Interested In…

Learn More About ADC

What is Beacon ADC?
  • The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
  • Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon ADC

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search